Roku, Inc. Free cash flow increased by 83.9% to $196.01M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 43.3%, from $136.80M to $196.01M. Over 3 years (FY 2022 to FY 2025), Free cash flow shows an upward trend with a 47.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $38.78M | $94.63M | $87.03M | -$149.19M | -$29.72M | -$58.03M | -$207.66M | $128.98M | $239.11M | $12.81M | $46.01M | $22.53M | $67.61M | $76.83M | $136.80M | $108.61M | $126.47M | $106.56M | $196.01M |
| QoQ Change | — | +144.0% | -8.0% | -271.4% | +80.1% | -95.2% | -257.9% | +162.1% | +85.4% | -94.6% | +259.3% | -51.0% | +200.1% | +13.6% | +78.0% | -20.6% | +16.4% | -15.7% | +83.9% |
| YoY Change | — | — | — | -484.7% | -131.4% | — | -338.6% | +186.5% | +904.5% | +122.1% | +122.2% | -82.5% | -71.7% | +499.9% | +197.3% | +382.1% | +87.1% | +38.7% | +43.3% |